Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort

NCT03900442 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
PTCL

Interventions

DRUG: PTX-100

Sponsor

Prescient Therapeutics, Ltd.